Metraipolis › archive › dc_35f5f645fd5b
KMT2D loss drives adeno-to-squamous transition and sensitizes TKI-resistant lung cancer to AURKA inhibition — Europe PMC PMID:41507359
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41507359
- DOI
- 10.1038/s41418-[numero omesso]-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T23:42:05.295Z
- SHA-256 of the archived text
1bd3f5295b80779eb12ae099d35db1920945615b7a5490d981f48b769ada51c7- Stable URL of this page
https://metraipolis.com/documento/dc_35f5f645fd5b
How to cite
KMT2D loss drives adeno-to-squamous transition and sensitizes TKI-resistant lung cancer to AURKA inhibition — Europe PMC PMID:41507359 — Europe PMC (en), https://europepmc.org/article/MED/41507359 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_35f5f645fd5b (Metraipolis archive dc_35f5f645fd5b, sha256 1bd3f5295b80779eb12ae099d35db1920945615b7a5490d981f48b769ada51c7)
BibTeX
@misc{dc35f5f645fd5b,
title = {KMT2D loss drives adeno-to-squamous transition and sensitizes TKI-resistant lung cancer to AURKA inhibition — Europe PMC PMID:41507359},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41507359},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_35f5f645fd5b; sha256 1bd3f5295b80779eb12ae099d35db1920945615b7a5490d981f48b769ada51c7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41507359. Agents can read the archived copy with the MCP tool read_document.